A comparison between ATG and PT-CY graft-versus-host-disease prophylaxis in patients with lymphoma undergoing reduced intensity conditioning regimen HSCT from 1 antigen MMUD Diseases Group Lymphoma Working Party (LWP) Principal investigator Annalisa Paviglianiti
Mesenchymal stem cells for treatment of steroid-resistant acute graft-versus-host disease Diseases Group Cellular Therapy & Immunobiology Working Party (CTIWP) Type of transplant Principal investigator Antonio Galleu
Allogeneic HSCT in adolescents and young adults (AYA) with primary immunodeficiency diseases (PID) Group Inborn Errors Working Party (IEWP) Principal investigator Emma Morris & Michael Albert
Outcomes of HLA-mismatched HSCT in patients with PID following in vitro T-cell depletion with CD3+TCRαβ/CD19 depleted PBSC or in vivo T-cell depleted HSCT with post-transplant cyclophosphamide Group Inborn Errors Working Party (IEWP) Principal investigator Mary Slatter & Michael Albert
Phase 2 trial to assess haploidentical a/ß T-depleted stem cell transplantation in patients with sickle cell disease with no available sibling donor (T-Haplo-HSCT for SCD) Study type Group Paediatric Diseases Working Party (PDWP) Principal investigator Selim Corbacioglu
Association of donor-recipient HLA matching with outcome of unrelated donor HCT Study type Diseases Group Cellular Therapy & Immunobiology Working Party (CTIWP) Type of transplant Principal investigator Katharina Fleischhauer
Update of EBMT survey: Identifying CARs centers and CAR activity in Europe, on behalf of the Cellular Therapy & Immunobiology Working Party Study type Diseases Group Cellular Therapy & Immunobiology Working Party (CTIWP) Type of transplant Principal investigator Alvaro Urbano-Ispizua
Donor lymphocyte infusions after haploidentical stem cell transplantation: a study on behalf of the cellular therapy & immunobiology working party of the EBMT Diseases Group Cellular Therapy & Immunobiology Working Party (CTIWP) Type of transplant Principal investigator Nicole Santoro
Immunodeficiency – centromeric instability – facial dysmorphism (ICF) syndrome: evaluation of characteristics and outcome after allogeneic haematopoietic stem cell transplantation Diseases Group Inborn Errors Working Party (IEWP) Principal investigator Dagmar Berghuis
Clinical and immunological outcome of CID patients with hypomorphic RAG mutations following HSCT Group Inborn Errors Working Party (IEWP) Principal investigator Catharina Schuetz & Benedicte Neven
Allogeneic hematopoietic stem cell transplantation for the BCR-ABL1 negative myeloproliferative neoplasms in children Group Paediatric Diseases Working Party (PDWP) Principal investigator Jacek Wachowiak
Thrombopoietin receptor agonists post HSCT in pediatric patients Diseases Group Paediatric Diseases Working Party (PDWP) Type of transplant Principal investigator Asaf David Yanir